Status: current, Defined. Date: 31-Jul 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3958651000168113 | Diavance 250/1.25 (glibenclamide 1.25 mg + metformin hydrochloride 250 mg) tablet, 90 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3958661000168110 | Diavance 250/1.25 tablet, 90 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Diavance 250/1.25 tablet, 90 | Is a | metformin hydrochloride 250 mg + glibenclamide 1.25 mg tablet, 90 | true | Inferred relationship | Some | ||
| Diavance 250/1.25 tablet, 90 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Diavance 250/1.25 tablet, 90 | has TPUU | Diavance 250/1.25 tablet | true | Inferred relationship | Some | 1 | |
| Diavance 250/1.25 tablet, 90 | has TP | Diavance 250/1.25 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Diavance 250/1.25 tablet, 90, blister pack | Is a | True | Diavance 250/1.25 tablet, 90 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR